#gene-therapy
Latest news and interesting information about gene-therapy.
Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy
Leerink reaffirms Eli Lilly stock rating with Outperform and $1,119 target, citing promising gene therapy data from VERVE-102 trial. Bond.az covers the latest.
Benitec Biopharma gene therapy stock shows clinical promise
Benitec Biopharma gene therapy stock shows clinical promise. BB-301 achieves 100% response rate in OPMD. Analysis on Bond.az.
Taysha stock hits all-time high
Taysha Gene Therapies stock hit $5.49 record high but retreated. Q1 results showed wider loss and no revenue. Bond.az reports.
Tenaya Reports Interim Gene Therapy Trial Results for Heart Condition
Tenaya Therapeutics reported interim results from its RIDGE-1 trial showing TN-401 gene therapy reduced heart rhythm disturbances by up to 67%. Shares up 114%.
...